341 related articles for article (PubMed ID: 19115524)
1. Genetics and molecular pathology of neuroendocrine gastrointestinal and pancreatic tumors (gastroenteropancreatic neuroendocrine tumors).
Oberg K
Curr Opin Endocrinol Diabetes Obes; 2009 Feb; 16(1):72-8. PubMed ID: 19115524
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
Starker LF; Carling T
Curr Opin Oncol; 2009 Jan; 21(1):29-33. PubMed ID: 19125015
[TBL] [Abstract][Full Text] [Related]
3. The molecular genetics of gastroenteropancreatic neuroendocrine tumors.
Zikusoka MN; Kidd M; Eick G; Latich I; Modlin IM
Cancer; 2005 Dec; 104(11):2292-309. PubMed ID: 16258976
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
Toumpanakis CG; Caplin ME
Am J Gastroenterol; 2008 Mar; 103(3):729-32. PubMed ID: 18341492
[TBL] [Abstract][Full Text] [Related]
5. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
Swarts DR; Ramaekers FC; Speel EJ
Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
[TBL] [Abstract][Full Text] [Related]
6. Genomic alterations in well-differentiated gastrointestinal and bronchial neuroendocrine tumors (carcinoids): marked differences indicating diversity in molecular pathogenesis.
Zhao J; de Krijger RR; Meier D; Speel EJ; Saremaslani P; Muletta-Feurer S; Matter C; Roth J; Heitz PU; Komminoth P
Am J Pathol; 2000 Nov; 157(5):1431-8. PubMed ID: 11073802
[TBL] [Abstract][Full Text] [Related]
7. Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors.
Stancu M; Wu TT; Wallace C; Houlihan PS; Hamilton SR; Rashid A
Mod Pathol; 2003 Dec; 16(12):1189-98. PubMed ID: 14681318
[TBL] [Abstract][Full Text] [Related]
8. Gastroenteropancreatic endocrine tumors.
Meeker A; Heaphy C
Mol Cell Endocrinol; 2014 Apr; 386(1-2):101-20. PubMed ID: 23906538
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
D'Adda T; Keller G; Bordi C; Höfler H
Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509
[TBL] [Abstract][Full Text] [Related]
10. Analysis of chromosome-11 aberrations in pulmonary and gastrointestinal carcinoids: an array comparative genomic hybridization-based study.
Petzmann S; Ullmann R; Halbwedl I; Popper HH
Virchows Arch; 2004 Aug; 445(2):151-9. PubMed ID: 15235910
[TBL] [Abstract][Full Text] [Related]
11. Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors.
Asa SL; La Rosa S; Basturk O; Adsay V; Minnetti M; Grossman AB
Endocr Pathol; 2021 Mar; 32(1):169-191. PubMed ID: 33459926
[TBL] [Abstract][Full Text] [Related]
12. [Detection of H-ras and K-ras in tumors of gastrointestinal-pancreatic system].
Liedke M; Karnbach C; Kalinin V; Herbst B; Frilling A; Broelsch CE
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):255-9. PubMed ID: 14518255
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathology of pancreatic neuroendocrine tumors.
Chen M; Van Ness M; Guo Y; Gregg J
J Gastrointest Oncol; 2012 Sep; 3(3):182-8. PubMed ID: 22943010
[TBL] [Abstract][Full Text] [Related]
14. Comparison of genetic alterations in neuroendocrine tumors: frequent loss of chromosome 18 in ileal carcinoid tumors.
Wang GG; Yao JC; Worah S; White JA; Luna R; Wu TT; Hamilton SR; Rashid A
Mod Pathol; 2005 Aug; 18(8):1079-87. PubMed ID: 15920555
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppressor genes in the 9p21 gene cluster are selective targets of inactivation in neuroendocrine gastroenteropancreatic tumors.
Lubomierski N; Kersting M; Bert T; Muench K; Wulbrand U; Schuermann M; Bartsch D; Simon B
Cancer Res; 2001 Aug; 61(15):5905-10. PubMed ID: 11479232
[TBL] [Abstract][Full Text] [Related]
16. [Genomics of neuroendocrine tumors of the lung and gastrointestinal tract: similarities and differences].
Tímár J; Patócs A
Magy Onkol; 2018 Jul; 62(2):77-82. PubMed ID: 30027934
[TBL] [Abstract][Full Text] [Related]
17. Malignancy-associated allelic losses on the X-chromosome in foregut but not in midgut endocrine tumours.
Pizzi S; D'Adda T; Azzoni C; Rindi G; Grigolato P; Pasquali C; Corleto VD; Delle Fave G; Bordi C
J Pathol; 2002 Apr; 196(4):401-7. PubMed ID: 11920735
[TBL] [Abstract][Full Text] [Related]
18. Multiple allelic deletions and intratumoral genetic heterogeneity in men1 pancreatic tumors.
Hessman O; Skogseid B; Westin G; Akerström G
J Clin Endocrinol Metab; 2001 Mar; 86(3):1355-61. PubMed ID: 11238532
[TBL] [Abstract][Full Text] [Related]
19. Chromosome 18 deletions are common events in classical midgut carcinoid tumors.
Löllgen RM; Hessman O; Szabo E; Westin G; Akerström G
Int J Cancer; 2001 Jun; 92(6):812-5. PubMed ID: 11351300
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis.
Ito T; Igarashi H; Nakamura K; Sasano H; Okusaka T; Takano K; Komoto I; Tanaka M; Imamura M; Jensen RT; Takayanagi R; Shimatsu A
J Gastroenterol; 2015 Jan; 50(1):58-64. PubMed ID: 24499825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]